Component: (Network and Table)
Network
00300 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS
(http://www.cardionet.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001574774 (http://www.sec.gov/CIK)
CONSOLIDATED STATEMENTS OF CASH FLOWSPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
 
Operating activities
 
 
 
Net income (loss)
53,437,000  
7,428,000  
(9,793,000) 
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
 
Bad debt expense
9,931,000  
8,047,000  
9,347,000  
Depreciation
10,547,000  
8,987,000  
8,858,000  
Non-cash lease expense (income)
170,000  
(14,000) 
355,000  
Non-cash tax (benefit) expense
(38,141,000) 
245,000  
(2,499,000) 
Stock-based compensation
6,502,000  
4,952,000  
4,037,000  
Amortization of intangibles
3,722,000  
3,501,000  
3,692,000  
Accretion of debt discount and amortization of deferred charges
217,000  
259,000  
 
Loss on extinguishment of debt
  
203,000  
Changes in operating assets and liabilities:
 
 
 
Healthcare and other accounts receivable
(8,707,000) 
(7,677,000) 
(12,795,000) 
Inventory
(753,000) 
188,000  
299,000  
Prepaid expenses and other assets
(763,000) 
(3,000) 
(128,000) 
Accounts payable
3,145,000  
(4,699,000) 
47,000  
Accrued and other liabilities
(456,000) 
(464,000) 
788,000  
Liability associated with the Civil Investigative Demand
 
(6,400,000) 
6,400,000  
Net cash provided by operating activities
38,851,000  
 
14,350,000  
 
8,811,000  
 
Investing activities
 
 
 
Acquisition of businesses, net of cash acquired
(24,970,000) 
 
(14,100,000) 
Purchases of property and equipment and investment in internally developed software
(10,899,000) 
(13,600,000) 
(12,781,000) 
Investment in equity method investee
(312,000) 
  
Net cash used in investing activities
(36,181,000) 
 
(13,600,000) 
 
(26,881,000) 
 
Financing activities
 
 
 
Proceeds related to the exercising of stock options and employee stock purchase plan
2,519,000  
1,222,000  
1,400,000  
Tax payments related to the vesting of shares
(2,333,000) 
(1,575,000) 
(349,000) 
Issuance of long-term debt
  
41,838,000  
Borrowings under revolving loans
14,500,000  
  
Principal payments on revolving loans
(11,500,000) 
  
Principal payments on long-term debt
(1,438,000) 
(938,000) 
(26,434,000) 
Principal payments on capital lease obligations
(321,000) 
(480,000) 
(529,000) 
Net cash provided by (used in) financing activities
1,427,000  
 
(1,771,000) 
 
15,926,000  
 
Effect of exchange rate changes on cash
(31,000) 
  
Net increase (decrease) in cash and cash equivalents
4,066,000  
 
(1,021,000) 
 
(2,144,000) 
 
Cash and cash equivalents-beginning of period
18,986,000  
20,007,000  
22,151,000  
Cash and cash equivalents-end of period
23,052,000  
 
18,986,000  
 
20,007,000  
 
Supplemental disclosure of cash flow information
 
 
 
Cash paid for interest
1,273,000  
1,044,000  
856,000  
Cash paid for taxes
359,000  
384,000  
148,000